Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

Masuda, Norikazu; Lee, Soo-Jung; Ohtani, Shoichiro; Im, Young‐Hyuck; Sook Lee, Eun; Yokota, Isao; Kuroi, Katsumasa; Im, Seock‐Ah; Park, Byeong‐Woo; Kim, Sung‐Bae; Yanagita, Yasuhiro; Ohno, Shinji; Takao, Shintaro; Aogi, Kenjiro; Iwata, Hiroji; Jeong, Joon; Kim, Aeree; Hwa Park, Kyong; Sasano, Hironobu; Ohashi, Yasuo; Toi, Masakazu

doi:10.1056/nejmoa1612645

Public

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

Published in New England Journal of Medicine • May 31, 2017

Authors:

Norikazu Masuda

Soo-Jung Lee

Shoichiro Ohtani

Abstract

BACKGROUND: Patients who have residual invasive carcinoma after the receipt of neoadjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-negative breast cancer have poor prognoses. The benefit of adjuvant chemotherapy in these patients remains unclear. METHODS: We randomly assigne...

Subject

Medicine

Capecitabine

Oncology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!